EQS-News: SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility
EQS-News: SCHOTT Pharma AG & Co. KGaA
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Strategic Company Decision/Expansion SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility 18.03.2024 / 18:40 CET/CEST The issuer is solely responsible for the content of this announcement. SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina
18 March 2024, Mainz, Germany
SCHOTT Pharma plans to make Wilson, North Carolina home to its newest site. The investment is supported by $21 million in state and local incentive awards and will expand SCHOTT Group’s presence in the United States, a strategic market in its growth plan.
18.03.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | SCHOTT Pharma AG & Co. KGaA |
Hattenbergstraße 10 | |
55122 Mainz | |
Germany | |
ISIN: | DE000A3ENQ51 |
WKN: | A3ENQ5 |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1861353 |
End of News | EQS News Service |
|
1861353 18.03.2024 CET/CEST